AI주식인사이트AI Stock Insight
C

지니너스

389030KOSDAQ자연과학 및 공학 연구개발업

45.8 / 100

Reference Date: 2026-07-24

Financial Score10.5 / 40
News Sentiment21.3 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Declined 6.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Geninus focuses on genomics, bioinformatics, and the development of in-vitro diagnostic medical devices, leveraging advanced technologies such as NGS and PCR to provide innovative healthcare solutions in early cancer detection, liquid biopsy, and precision medicine. The company also conducts research on mutations and biomarkers to support disease prognosis prediction and personalized treatment strategies.

Number of Employees

59people

Average Salary

72.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 43.644.0Point
PBR
9.18Industry Average 2.520.0Point

3.6x industry avg (risky)

ROE
-110.87Industry Average -32.093.5Point

3.5x industry avg (excellent)

Debt Ratio
18.72Industry Average 7.310.0Point

2.6x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲27.5% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼8.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -59.7% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 2,120Won52-week high 6,27052-week low 1,505
1-month return2.0Point

1m -6.40% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0